The role of binding ligand in toxic hybrid proteins: a comparison of EGF-ricin, EGF-ricin A-chain, and ricin.
To analyze the influence of ricin B-chain on the toxicity of hybrid-protein conjugates, the rate of cellular uptake of conjugates, and the rate at which ricin A-chain (RTA) is delivered to the cytoplasm, we have constructed toxic hybrid proteins consisting of epidermal growth factor (EGF) coupled in disulfide linkage either to ricin or to RTA. EGF-ricin is no more toxic on A431 cells than EGF-RTA. The two conjugates demonstrate similar kinetics of cellular uptake (defined as antibody irreversible toxicity). EGF-RTA and EGF-ricin, like ricin, required a 2-2 1/2 hour period at 37 degrees before the onset of protein synthesis inhibition occurred. Our results suggest that RTA determines the processes which carry it, either in conjugate or toxin, from the plasma membrane binding site to the cytoplasm following endocytosis, and the ricin B chain is not required for these processes.
D001692:Biological Transport; D002294:Carcinoma, Squamous Cell; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000378:metabolism* / Q000633:toxicity; D006801:Humans; D007700:Kinetics; D010940:Plant Proteins / Q000378:metabolism; D014176:Protein Biosynthesis / Q000187:drug effects; D055503:Protein Multimerization; D011975:Receptors, Mitogen / Q000378:metabolism; D012276:Ricin / Q000378:metabolism* / Q000633:toxicity; D013329:Structure-Activity Relationship
D010940:Plant Proteins; D011975:Receptors, Mitogen; C032650:Ricinus communis lectin receptor; C043185:epidermal growth factor-ricin complex; D004815:Epidermal Growth Factor; D012276:Ricin